Titlebook: Cardio-Oncology; The Clinical Overlap Gretchen G. Kimmick,Daniel J. Lenihan,Dawn L. Hers Book 2017 Springer International Publishing Switze

廢除

bile648

Screening and Monitoring for Cardiotoxicity During Cancer Treatment,led to increased survivorship; however, these treatments may contribute to cardiovascular morbidity and mortality that threaten to undermine cancer-specific survival gains. The new subspecialty of “cardio-oncology” aims to keep pace with the rapid evolution of cancer therapies and the incidence, mag

笨拙的我

Management of Chemotherapy-Associated Cardiomyopathy,ular complications of cancer therapies has increased with the introduction of novel combinations and with new targeted biologic therapies [1]. There are many well-documented, long-term cardiovascular complications of chemotherapy including cardiomyopathy, myocardial infarction, and arrhythmia [2]. T

考得

減震

百靈鳥

Radiation Therapy and Cardiotoxicity,pidemiology of heart disease after radiotherapy, with specific focus on clinical data from Hodgkin lymphoma?and breast cancer survivors. As clinical manifestation of heart disease can take years, if not decades, to manifest, animal models can assist in our understanding of the pathogenesis as well a

intrigue

CROAK

典型

FOLLY

Geriatric Cardio-oncology,ly vulnerable to cardiotoxicity from cancer treatment. Cardiotoxicity results from several factors in older patients: age-related factors, direct cardiac injury related to certain chemotherapy drugs (anthracyclines, trastuzumab, tyrosine kinase inhibitors, platinums, etc.), and changes in functional